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NecrosisIn this study we aim to elucidate the signaling pathway and biological function of autophagy
induced by MNNG, a commonly used DNA alkylating agent. We ﬁrst observed that MNNG is able
to induce necrotic cell death and autophagy in Bax/ Bak/ double knockout MEFs. We analyzed
the critical role of PARP-1 activation and ATP depletion in MNNG-mediated cell death and autoph-
agy via AMPK activation and mTOR suppression. We provide evidence that suppression of AMPK
blocks MNNG-induced autophagy and enhances cell death, suggesting the pro-survival function of
autophagy in MNNG-treated cells. Taken together, data from this study reveal a novel mechanism
in controlling MNNG-mediated autophagy via AMPK activation downstream of PARP-1 activation
and ATP depletion.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
DNA alkylating agents are capable of inducing DNA damage by
attaching an alkyl group to DNA, and have been widely used as
chemotherapeutic drugs in cancer chemotherapy [1,2]. On the
other hand, PARP-1 is the founding member of the PARP family,
a group of nuclear enzymes that play a critical role in DNA damage
repair through poly(ADP-ribosyl)ation [3]. It is known that poly-
(ADP-ribosyl)ation is an energetically expensive process, causing
rapid depletion of cellular b-nicotinamide adenine dinucleotide
(NAD+), failure in ATP production, and eventually necrotic cell
death [4]. It has been reported that N-methyl-N0-nitro-N-nitroso-
guanidine (MNNG), a commonly used alkylating agent, kills cells
by necrosis through massive production of DNA strand breaks,
over-activation of PARP and ATP depletion [5,6].
Macroautophagy (referred as autophagy hereafter in this
study) is a cellular catabolic degradation process in response tostarvation or other stress conditions whereby cellular proteins
and organelles are engulfed to autophagosomes and eventually
digested via lysosomes to sustain cellular homeostasis [7,8].
Although it is still controversial regarding the role of autophagy
in cell death or cell survival, accumulating evidence tends to sug-
gest that autophagy generally serves as a pro-survival mecha-
nisms, especially under stress conditions, such starvation,
oxidative stress, metabolic stress and DNA damage [9–11]. So
far, there are limited reports regarding the involvement of
autophagy in the response to DNA alkylating agents. An early
study showed that MNNG induced obvious increase of autophagic
vacuoles in syrian golden hamster pancreatic organ explants [12].
Moreover, MNNG treatment was reported to induce autophagy in
Myc/p53ERTAM lymphoma cells in vivo and knockdown of ATG5
signiﬁcantly sensitized MNNG-induced cytotoxic effect [13], sug-
gesting that autophagy serves as a survival pathway in tumor
cells treated with alkylating agents. At present the signaling path-
ways involved in alkylating agent-induced autophagy are still elu-
sive. In this study we have identiﬁed that PARP-1 activation, ATP
depletion and subsequent activation of AMP-activated protein ki-
nase (AMPK) play an important role in the induction of autophagy
and such autophagy serves as a pro-survival function in MNNG-
induced necrotic cell death.
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Fig. 1. MNNG induces caspase-independent necrotic cell death and autophagy. (A) DKO MEFs were pretreated with or without zVAD (50 lM) and exposed to MNNG
(100 lM) for 24 h. Cell death was examined under microscope for morphological changes. (B) DKO MEFs were treated designated concentration of MNNG for 24 h, with or
without zVAD. Cell viability was quantiﬁed by the PI exclusion assay coupled with ﬂow cytometry. (C) DKO MEFs were exposed to MNNG (100 lM) for 24 h or TNFa (25 ng/
ml) plus CHX (10 lg/ml) for 12 h in the presence or absence of zVAD (50 lM) and caspase-3 and PARP cleavage were detected by Western blot. (D) DKO MEFs were
transfected with either control or RIP3 siRNA for 48 h, and cells were subsequently treated with MNNG (100 lM) for 24 h. (E) Morphological changes were examined under
the microscope in cells as treated in (D). (F) Cell viability was measured using the same method as in (B) after the same treatment as in (D). (G) DKO MEF cells were treated
with DMSO (control) or MNNG (100 lM), with or without necrostatin-1 (30 lM) for 24 h. Morphological pictures were captured under the microscope. (H) Cell viability was
measured using the same method as in (B) after the same treatment as in (G). Data in panels B, F and H were presented as mean ± S.D. from three independent experiments.
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2.1. Reagents
MNNG, rapamycin, chloroquine (CQ), cycloheximide (CHX),
propidium iodide (PI), ATP detection kit, and anti-tubulinantibody were purchased from Sigma (St. Louis, MO, USA). 3,4-
Dihydro-5[4-(1-piperindinyl)butoxy]-1(2H)-isoquinoline (DPQ),
necrostatin-1 and Compound C were from Calbiochem (San Diego,
CA, USA). Pan-caspase inhibitor z-VAD-FMK was purchased from
BioMol (Plymouth meeting, PA, USA). Antibodies against PARP-1,
caspase-3, phospho-AMPK, AMPK, and phospho-p70S6K were
172 J. Zhou et al. / FEBS Letters 587 (2013) 170–177purchased from Cell Signaling (Beverly, MA, USA); anti-PAR anti-
body was from Trevigen (Gaithersburg, MD) and anti-RIP3 was
from ProSci (Poway, CA, USA). Antibody against LC3 was pur-
chased from Sigma–Aldrich (St. Louis, Missouri, USA). Mouse re-
combinant TNFa was obtained from R&D (Minneapolis, MN,
USA). Mouse AMPKa siRNA was purchased from Santa Cruz (San-
ta Cruz, CA, USA). The ON-TARGETplus SMARTpool mouse Atg7
(#L-049953-00-0005), PARP-1 (#L-040023-00-0005), RIPK3 (#L-
049919-00-0005), and a non-speciﬁc targeting ON-TARGETplus
(#D-001810-10-05) siRNA were from Dharmacon Inc. (Lafayette,
CO, USA).
2.2. Cell culture and MNNG treatment
Bax/ Bak/ double knockout (DKO) MEFs were kindly pro-
vided by Dr. Emily H.-Y. Cheng (Washington University, St. Louis,
USA) and cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) (Hyclone) in a 5%
CO2 atmosphere at 37 C. For MNNG treatment, cells were treated
in full mediumwith MNNG for 15 min. Cells were then washed and
fed with fresh medium without MNNG and cultured for the indi-
cated incubation periods.
2.3. Detection of cell death
Cell death was measured and quantiﬁed by (i) morphological
changes examined under the light microscope, and (ii) live cell PI
exclusion test coupled with ﬂow cytometry, following established
methods in our laboratory [14].A
B
D
Fig. 2. Autophagy plays a pro-survival role in MNNG-induced cell death (A) DKO MEFs w
Western blot. (B) DKO MEFs were treated with MNNG (100 lM) with or without the pres
with either control or ATG7 siRNA. Cells were then treated with MNNG (100 lM), and cel
(B) and cell death was quantiﬁed using the PI exclusion test coupled with ﬂow cytometr
and cell death was quantiﬁed using the PI exclusion test coupled with ﬂow cytometry
mean ± S.D. from three independent experiments (⁄⁄P < 0.01, t-test).2.4. Western blotting
After designated treatments, cell were collected and washed
once in PBS. Cell pellets were lysed in lysis buffer (50 mM Tris–
HCl, pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl,
1 mM EGTA, 1 mM PMSF, 1 mM Na3VO4, 1 mM NaF) with protease
inhibitor cocktail (Roche). Western blotting was then performed
following the established methods in our laboratory [15].
2.5. ATP measurement
Intracellular ATP was extracted from cells in the exponential
phase of growth and measured by the luciferin/luciferase method
using a bioluminescent somatic cell assay kit (Sigma) in accor-
dance with the manufacturer’s protocol. In brief, at the end of
experiments, cells were collected using ice-cold cell dissociation
solution (Sigma) and resuspended in ice-cold PBS (pH = 7.8). Cells
were incubated with freshly prepared ATP assay mix and ATP
releasing reagent and subjected to bioluminescent detection. The
ATP level was presented as percentage to the untreated control
group.
2.6. Transient siRNA transfection
Cells were transfected with 100 nM smartpool siRNA of Atg7,
PARP-1, AMPKa, and RIPK3, together with a non-targeting siRNA
control (from Dharmacon) using DharmaFECT™ 4 siRNA Trans-
fection Reagent (Dharmacon) according to the supplier’s
protocol.C
E
ere treated with MNNG (100 lM) as designated and the LC3-II level was detected by
ence of CQ (40 lM) for detection of autophagic ﬂux. (C) DKO MEFs were transfected
l lysates were subjected to Western blot. (D) Cells were treated as described in panel
y when treated with MNNG for 24 h. (E) Cells were treated as described in panel (C)
when treated with MNNG for 24 h. Data in both panel D and E were presented as
J. Zhou et al. / FEBS Letters 587 (2013) 170–177 1732.7. Statistics
The results obtained from each experiment are expressed as
mean ± standard deviation (SD) from at least three independent
experiments. The signiﬁcance level was set at P < 0.05 for each
analysis using student’s t-test.3. Results
3.1. MNNG induces autophagy to protect against non-apoptotic cell
death
Here we ﬁrst examined MNNG-induced cell death in DKOMEFs,
a cell line that is deﬁcient of mitochondria-dependent apoptosis
pathway and widely used in study of necrosis [16]. MNNG induced
signiﬁcant cell death concentration-dependently, based on mor-
phological changes (Fig. 1A) and cell viability assay (Fig. 1B). Nota-
bly, no caspase 3 and PARP cleavage was observed in cells treated
with MNNG (Fig. 1C). zVAD, a pan-caspase inhibitor, failed to block
MNNG-induced cell death (Fig. 1A). To conﬁrm the effectiveness of
zVAD as a pan-caspase inhibitor, we tested cells treated with
CHX + TNFa as a positive control of apoptosis and found that zVAD
completely blocked TNFa-induced caspase 3 and PARP cleavage
(Fig. 1C). These ﬁndings indicate that MNNG induces caspase-inde-
pendent necrotic cell death in DKO MEFs, which are consistent
with the previous ﬁndings [17]. Similar results were also observed
in MNNG-treated L929 mouse sarcoma cells and p53/ HCT116
colon cancer cells (data not shown). Necroptosis is a form of
non-apoptotic cell death involving RIP1-RIP3 signaling pathway
and could be blocked by necrostin-1 [18,19]. Here we performed0 0.5 1 2 0 0.5 1 2
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Fig. 3. Suppression of PARP-1 rescues MNNG-induced cell death. (A) MNNG-induced PA
pretreatment of DPQ (10 lM), and the formation of PAR polymer was detected using Wes
ATP level. Data were shown as means ± S.D. of three independent experiments (C) Cells w
(10 lM). Cell viability was measured using the PI exclusion test coupled with ﬂow cytom
t-test). (D) DKOMEFs were ﬁrst subjected to PARP-1 siRNA knockdown, and then treated
measured as in panel B. (F) Cells with PARP-1 knockdown were treated with MNNG (100 l
shown as means ± S.D. of three independent experiments (⁄⁄P < 0.01, t-test).RIP3 knockdown assay (Fig. 1D) and found that RIP3 knockdown
failed to have any marked effect on MNNG-mediated cell death,
based on both cell morphology and cell viability measured by the
PI-exclusion test (Fig. 1E and F). Similar negative results were also
found in cells treated with necrostatin-1 (Fig. 1G and H). Therefore,
MNNG is likely to induce a form of necrotic cell death belong to
either Parthanatos’’ based on the new recommendation by the
Nomenclature Committee on Cell Death (NCCD) [19] or ‘‘PARP-
mediated necrotic cell death’’ based on the previous classiﬁcation
[18].
3.2. Autophagy is a protective mechanism in MNNG-induced cell death
Next we examined the autophagic response in cells treated with
MNNG. As shown in Fig. 2A, there was signiﬁcant increase of LC3-II
in DKO MEFs treated with MNNG, from 2 h onwards. Similar in-
crease of LC3-II was also observed in p53/ HCT116 colon cancer
cells (data not shown). More importantly, the presence of CQ fur-
ther increased the LC3-II level (Fig. 2B), suggesting that MNNG is
capable of promoting autophagy ﬂux. Finally, we attempted to
determine the role of autophagy in MNNG-induced necrotic cell
death by suppression of autophagy. First, autophagy was blocked
by knockdown of ATG7. As shown in Fig. 2C, knockdown of ATG7
almost completely abolished the formation of LC3-II. Notably,
knockdown of ATG7 signiﬁcantly sensitized MNNG-induced cell
death (Fig. 2E). Second, we tested the effect of CQ on MNNG-
induced cell death and as shown in Fig. 2D, CQ markedly reduced
the percentage of viable cells as determined by the PI live cell
exclusion test. Taken together, these results indicate that autoph-
agy acts as a cell survival mechanism in MNNG-induced necrotic
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necrotic cell death
After establishing the pro-survival role of autophagy in MNNG-
induced necrotic cell death, here we set to investigate the up-
stream signaling pathways controlling MNNG-mediated cell death.A
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J. Zhou et al. / FEBS Letters 587 (2013) 170–177 175activation in cell death induced by MNNG, we used a speciﬁc
chemical PARP inhibitor, DPQ [23]. DPQ markedly reduced the
PAR formation (Fig. 3A), enhanced the intracellular ATP level
(Fig. 3B) and effectively suppressed MNNG-induced cell death
(Fig. 3C). Next, we used a genetic approach to knockdown PARP-
1 using siRNA. PARP-1 knockdown almost completely abolished
MNNG-induced PARP-1 activation (Fig. 3D), restored ATP level
(Fig. 3E) and prevented MNNG-induced cell death (Fig. 3F). These
data collectively suggest that PARP-1 activation and subsequent
ATP depletion plays a critical role in MNNG-induced necrotic cell
death.
3.4. AMPK mediates autophagy downstream of PARP activation in
MNNG-treated cells
After establishing the role of PARP activation MNNG-induced
cell death, here we aimed to study the signaling events down-
stream of PARP activation in MNNG-treated cells. Based on the
well-established role of AMPK in autophagy via inhibition of
mTOR [24,25], we hypothesize that, in response to MNNG-
induced PARP-1 activation and ATP depletion, AMPK activation
and subsequent mTOR inhibition might contribute to the induc-
tion of autophagy. To verify this, we ﬁrst examined the changes
of AMPK and mTOR activity in cells treated with MNNG. As shown
in Fig. 4A and B, treatment with MNNG markedly enhanced PARformation, with concurrent increase of p-AMPK level and reduc-
tion of p-p70S6K, suggesting the close association between
PARP-AMPK activation and mTOR suppression. In order to estab-
lish the causative role of PARP-1 in MNNG-induced AMPK activa-
tion, mTOR suppression and autophagy induction, we used two
different approaches to block PARP function, First, a chemical
inhibitor DPQ markedly blocked MNNG-induced AMPK activation,
restored the phosphorylation of p70S6K, and subsequently re-
duced LC3-II level (Fig. 4A). Second, similar effect was also found
in cells with PARP-1 siRNA knockdown (Fig. 4B). Taken together, it
is clearly indicated that MNNG-induced AMPK activation, mTOR
suppression and autophagy induction is mediated by PARP-1 acti-
vation and ATP depletion.
3.5. Inhibition of AMPK sensitizes MNNG-induced cell death via
suppression of autophagy
In this part of our study, we ﬁrst examined the effect of a spe-
ciﬁc chemical inhibitor of AMPK, Compound C [26]. As shown in
Fig. 5A, Compound C signiﬁcantly suppressed MNNG-induced acti-
vation of AMPK and restored the phosphorylation of p70S6K, lead-
ing to reduction of LC3-I to LC3-II conversion. Notably, Compound
C also enhanced MNNG-induced cell death (Fig. 5B). Compound C
was recently reported to stimulate autophagy via a mechanism
independent of AMPK [27]. In order to substantiate the ﬁndings
from the chemical inhibitor, we used a genetic approach by AMPK
knockdown. As shown in Fig. 5C, AMPK knockdown remarkably
inhibited AMPK activation (shown by reduction of p-AMPK level)
and reversed the inhibitory effect of MNNG on p70S6K phosphor-
ylation, and subsequently suppressed LC3-I to LC3-II conversion
(Fig. 5C). Similarly, AMPK knockdown also sensitized MNNG-
induced cell death (Fig. 5D). Moreover, in order to further test
the pro-survival function of autophagy in MNNG-mediated cell
death, cells were treated with rapamycin, a speciﬁc inhibitor of
mTOR, together with MNNG in Bax-Bak DKO MEFs. Rapamycin
markedly reduced p-p70S6K level and increased LC3-II (Fig. 5E)
and was able to offer signiﬁcant protection against MNNG-induced
cell death (Fig. 5F). It is thus believed that AMPK activation is an
important pro-survival mechanism in MNNG-induced cell death
via suppression of mTOR and activation of autophagy.
4. Discussion
Although autophagy is known to be implicated in the therapeu-
tic effect of DNA alkylating agents such as MNNG [28–30], the
molecular mechanisms underlying autophagy induced by MNNG
remain largely elusive. In this study, we present evidence showing
that PARP-1 activation following MNNG-induced DNA damage
leads to pro-survival autophagy via the AMPK-mTOR signaling
pathway. Therefore, PARP-1 appears to have dual roles in deter-
mining the cell fate in response to MNNG (summarized in
Fig. 5G): (i) PARP-1 activation is the cause of non-apoptotic cell
death via ATP depletion depletion [4,31]; and (ii) PARP-1 activation
is able to elicit a self-protective mechanism by induction of
autophagy. Our ﬁndings are indeed generally consistent with a
very recent report on MNNG-induced necrotic cell death in human
embryonic kidney HEK293 via PARP1 activation, ATP depletion,
AMPK activation and mTOR suppression [32], although the role
of autophagy was less studied.
One of the key ﬁndings of this study is the critical role of AMPK
in MNNG-induced autophagy and cell death, downstream of PARP-
1 activation and ATP depletion. AMPK is a well-conserved hetero-
trimeric kinase complex composed of a catalytic (a) subunit and
two regulatory (b and c) subunits. Serving as a cellular fuel gauge,
AMPK is activated under stress conditions, particularly those that
decrease ATP levels while increasing the AMP:ATP ratio, such as
176 J. Zhou et al. / FEBS Letters 587 (2013) 170–177hypoxia, ischeamia and glucose starvation [33]. At present, AMPK
has been increasingly appreciated as one of the key tumor suppres-
sors via suppression of mTOR and activation of autophagy [24,25].
AMPK serves as an important kinase that negatively regulates
mTOR activity, through the following two pathways: (i) activated
AMPK phosphorylates and stimulates the GAP activity of TSC1/
TSC2 complex, causing conversion of GTPase Rheb to its inactive
GDP from, and subsequently leads to the downregulation of mTOR
activity [33]; and (ii) activated AMPK suppresses mTOR function by
direct phosphorylation of raptor, an essential component of the
mTOR complex I (mTORC1), on two well-conserved serine residues
[34]. On the other hand, there is strong evidence setting AMPK as a
key upstream regulator of autophagy. First, AMPK activation may
lead to autophagy via suppression of mTORC1 as discussed above.
Second, recent studies have set AMPK as the direct upstream acti-
vator of autophagy via its direct effect on ULK1, the ATG1 homolog
in mammalians that plays a key role in autophagy initiation stage
[35,36]. Consistently, data from our study demonstrate that activa-
tion of AMPK leads to suppression of mTORC1 and induction of
autophagy in cells exposing to MNNG. In fact, the effect of MNNG
is found be similar to that of hydrogen peroxide which is known to
elicit a pro-survival autophagy via activation of PARP-1-AMPK and
suppression of mTOR in both DKO MEFs and human cancer cells
[37]. Therefore, our ﬁndings may represent a general mode of reac-
tion in cancer cells in response to DNA damage.
After establishing the signaling pathway in MNNG-mediated
autophagy, we then studied the function role of autophagy in
MNNG-mediated necrotic cell death. Data from this study clearly
suggest that autophagy is a cell survival mechanism in MNNG-
induced cell death, based on the observations that suppression of
autophagy by knockdown of ATG7 or blockage of lysosomal func-
tion by CQ sensitizes MNNG-induced cell death. Our data are found
to be consistent with the earlier report that alkylating agent in-
duces the pro-survival autophagy [13]. The pro-survival function
of autophagy was further supported by the ﬁndings that induction
of autophagy by rapamycin was able to offer signiﬁcant protection
against MNNG-mediated cell death. At present, there is growing
understanding that autophagy is a protective mechanism under
stress conditions, especially against necrotic cell death, with evi-
dence from a series of in vivo studies in which autophagy is found
to inhibit necrotic cell death of cancer cells under metabolic stress
[38–40]. Therefore, targeting autophagy or its upstream signaling
pathways (PARP-1-AMPK-mTOR) should be considered in develop-
ing more effective cancer therapeutic approaches.
In conclusion, as illustrated in Fig. 5G, in response to MNNG-
induced DNA damage, PARP-1 appears to have dual roles in deter-
mining the cell fate in response to MNNG: PARP-1 activation is the
cause of non-apoptotic cell death via ATP depletion and PARP-1
activation is able to elicit a self-protective mechanism by induction
of autophagy via the AMPK-mTOR pathway. Our ﬁndings thus pro-
vide novel insights into the complex relationship among alkylating
agent-induced DNA damage, autophagy and cell death.
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